Azenta Inc (AZTA)
42.29
-0.34
(-0.79%)
USD |
NASDAQ |
Nov 15, 10:51
Azenta Cash and Short Term Investments (Quarterly): 595.84M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 595.84M |
| March 31, 2024 | 821.71M |
| December 31, 2023 | 984.14M |
| September 30, 2023 | 1.018B |
| June 30, 2023 | 1.124B |
| March 31, 2023 | 1.181B |
| December 31, 2022 | 1.131B |
| September 30, 2022 | 1.570B |
| June 30, 2022 | 2.183B |
| March 31, 2022 | 2.753B |
| December 31, 2021 | 215.22M |
| September 30, 2021 | 227.51M |
| June 30, 2021 | 269.96M |
| March 31, 2021 | 320.21M |
| December 31, 2020 | 308.57M |
| September 30, 2020 | 250.70M |
| June 30, 2020 | 256.77M |
| March 31, 2020 | 242.44M |
| December 31, 2019 | 346.55M |
| September 30, 2019 | 335.77M |
| June 30, 2019 | 156.89M |
| March 31, 2019 | 137.26M |
| December 31, 2018 | 135.82M |
| September 30, 2018 | 243.99M |
| June 30, 2018 | 221.47M |
| Date | Value |
|---|---|
| March 31, 2018 | 234.67M |
| December 31, 2017 | 218.00M |
| September 30, 2017 | 101.65M |
| June 30, 2017 | 117.09M |
| March 31, 2017 | 105.43M |
| December 31, 2016 | 83.81M |
| September 30, 2016 | 85.12M |
| June 30, 2016 | 66.13M |
| March 31, 2016 | 62.23M |
| December 31, 2015 | 55.61M |
| September 30, 2015 | 150.74M |
| June 30, 2015 | 141.22M |
| March 31, 2015 | 142.50M |
| December 31, 2014 | 136.41M |
| September 30, 2014 | 162.24M |
| June 30, 2014 | 172.62M |
| March 31, 2014 | 135.56M |
| December 31, 2013 | 123.44M |
| September 30, 2013 | 128.87M |
| June 30, 2013 | 103.09M |
| March 31, 2013 | 106.36M |
| December 31, 2012 | 102.99M |
| September 30, 2012 | 140.28M |
| June 30, 2012 | 149.17M |
| March 31, 2012 | 152.21M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
215.22M
Minimum
Dec 2021
2.753B
Maximum
Mar 2022
831.56M
Average
595.84M
Median
Jun 2024
Cash and Short Term Investments (Quarterly) Benchmarks
| Bruker Corp | 148.10M |
| Harvard Bioscience Inc | 4.569M |
| Bionano Genomics Inc | 18.94M |
| Akoya Biosciences Inc | 45.22M |
| Singular Genomics Systems Inc | 133.20M |